| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.097 | 0.08 |